Table of Contents

1 Market Overview
1.1 Glucagon Introduction
1.2 Market Analysis by Type
1.2.1 Inject Glucagon
1.2.2 Nasal Glucagon
1.3 Market Analysis by Applications
1.3.1 Emergency Kits
1.3.2 General Use
1.3.3 Diagnostic & Motility
1.3.4 Cardiogenic Shock
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Business Overview
2.1.2 Glucagon Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Novo Nordisk Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Glucagon Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Eli Lilly Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Fresenius Kabi
2.3.1 Business Overview
2.3.2 Glucagon Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Fresenius Kabi Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Torrent Labs
2.4.1 Business Overview
2.4.2 Glucagon Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Torrent Labs Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Taj Pharmaceuticals
2.5.1 Business Overview
2.5.2 Glucagon Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Taj Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Xeris Pharmaceuticals
2.6.1 Business Overview
2.6.2 Glucagon Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Xeris Pharmaceuticals Glucagon Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Glucagon Market Competition, by Manufacturer
3.1 Global Glucagon Sales and Market Share by Manufacturer
3.2 Global Glucagon Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Glucagon Manufacturer Market Share
3.3.2 Top 6 Glucagon Manufacturer Market Share
3.4 Market Competition Trend
4 Global Glucagon Market Analysis by Regions
4.1 Global Glucagon Sales, Revenue and Market Share by Regions
4.1.1 Global Glucagon Sales by Regions (2012-2017)
4.1.2 Global Glucagon Revenue by Regions (2012-2017)
4.2 North America Glucagon Sales and Growth (2012-2017)
4.3 Europe Glucagon Sales and Growth (2012-2017)
4.4 Asia-Pacific Glucagon Sales and Growth (2012-2017)
4.5 South America Glucagon Sales and Growth (2012-2017)
4.6 Middle East and Africa Glucagon Sales and Growth (2012-2017)
5 North America Glucagon by Countries
5.1 North America Glucagon Sales, Revenue and Market Share by Countries
5.1.1 North America Glucagon Sales by Countries (2012-2017)
5.1.2 North America Glucagon Revenue by Countries (2012-2017)
5.2 USA Glucagon Sales and Growth (2012-2017)
5.3 Canada Glucagon Sales and Growth (2012-2017)
5.4 Mexico Glucagon Sales and Growth (2012-2017)
6 Europe Glucagon by Countries
6.1 Europe Glucagon Sales, Revenue and Market Share by Countries
6.1.1 Europe Glucagon Sales by Countries (2012-2017)
6.1.2 Europe Glucagon Revenue by Countries (2012-2017)
6.2 Germany Glucagon Sales and Growth (2012-2017)
6.3 UK Glucagon Sales and Growth (2012-2017)
6.4 France Glucagon Sales and Growth (2012-2017)
6.5 Russia Glucagon Sales and Growth (2012-2017)
6.6 Italy Glucagon Sales and Growth (2012-2017)
7 Asia-Pacific Glucagon by Countries
7.1 Asia-Pacific Glucagon Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Glucagon Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Glucagon Revenue by Countries (2012-2017)
7.2 China Glucagon Sales and Growth (2012-2017)
7.3 Japan Glucagon Sales and Growth (2012-2017)
7.4 Korea Glucagon Sales and Growth (2012-2017)
7.5 India Glucagon Sales and Growth (2012-2017)
7.6 Southeast Asia Glucagon Sales and Growth (2012-2017)
8 South America Glucagon by Countries
8.1 South America Glucagon Sales, Revenue and Market Share by Countries
8.1.1 South America Glucagon Sales by Countries (2012-2017)
8.1.2 South America Glucagon Revenue by Countries (2012-2017)
8.2 Brazil Glucagon Sales and Growth (2012-2017)
8.3 Argentina Glucagon Sales and Growth (2012-2017)
8.4 Columbia Glucagon Sales and Growth (2012-2017)
9 Middle East and Africa Glucagon by Countries
9.1 Middle East and Africa Glucagon Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Glucagon Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Glucagon Revenue by Countries (2012-2017)
9.2 Saudi Arabia Glucagon Sales and Growth (2012-2017)
9.3 UAE Glucagon Sales and Growth (2012-2017)
9.4 Egypt Glucagon Sales and Growth (2012-2017)
9.5 Nigeria Glucagon Sales and Growth (2012-2017)
9.6 South Africa Glucagon Sales and Growth (2012-2017)
10 Global Glucagon Market Segment by Type
10.1 Global Glucagon Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Glucagon Sales and Market Share by Type (2012-2017)
10.1.2 Global Glucagon Revenue and Market Share by Type (2012-2017)
10.2 Inject Glucagon Sales Growth and Price
10.2.1 Global Inject Glucagon Sales Growth (2012-2017)
10.2.2 Global Inject Glucagon Price (2012-2017)
10.3 Nasal Glucagon Sales Growth and Price
10.3.1 Global Nasal Glucagon Sales Growth (2012-2017)
10.3.2 Global Nasal Glucagon Price (2012-2017)
11 Global Glucagon Market Segment by Application
11.1 Global Glucagon Sales Market Share by Application (2012-2017)
11.2 Emergency Kits Sales Growth (2012-2017)
11.3 General Use Sales Growth (2012-2017)
11.4 Diagnostic & Motility Sales Growth (2012-2017)
11.5 Cardiogenic Shock Sales Growth (2012-2017)
11.6 Others Sales Growth (2012-2017)
12 Glucagon Market Forecast (2017-2022)
12.1 Global Glucagon Sales, Revenue and Growth Rate (2017-2022)
12.2 Glucagon Market Forecast by Regions (2017-2022)
12.2.1 North America Glucagon Market Forecast (2017-2022)
12.2.2 Europe Glucagon Market Forecast (2017-2022)
12.2.3 Asia-Pacific Glucagon Market Forecast (2017-2022)
12.2.4 South America Glucagon Market Forecast (2017-2022)
12.2.5 Middle East and Africa Glucagon Market Forecast (2017-2022)
12.3 Glucagon Market Forecast by Type (2017-2022)
12.4 Glucagon Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source